• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 401/10 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings

Patent holdings for IPC class C07D 401/10

Total number of patents in this class: 2841

10-year publication summary

237
237
245
234
190
177
154
145
126
99
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4748
87
Merck Patent GmbH
5735
64
LG Chem, Ltd.
17937
60
Takeda Pharmaceutical Company Limited
2712
56
Novartis AG
10178
55
Merck Sharp & Dohme LLC
3736
48
Samsung Display Co., Ltd.
38791
44
Gilead Sciences, Inc.
2231
38
Tosoh Corporation
1418
36
F. Hoffmann-La Roche AG
7815
34
Boehringer Ingelheim International GmbH
4483
33
VALO Health, Inc.
193
32
Janssen Pharmaceutica N.V.
3161
31
Hodogaya Chemical Co., Ltd.
431
29
Novaled GmbH
486
26
Hoffmann-La Roche Inc.
3815
25
Abbvie Inc.
1822
24
Idemitsu Kosan Co., Ltd.
4251
23
Bayer Pharma AG
1010
20
Genentech, Inc.
4115
19
Other owners 2057